Transintestinal cholesterol excretion: A secondary, nonbiliary pathway contributing to reverse cholesterol transport

Hepatology

Volumn 66, Issue 4, 2017, Pages 1337-1340

  Wang, David Q H ^a   Portincasa, Piero ^b   Tso, Patrick ^c  

^a MARION BESSIN LIVER RESEARCH CENTER   (United States)

^b UNIVERSITY OF BARI   (Italy)

^c UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BILE ACID; CHOLESTEROL; LIVER X RECEPTOR; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR DELTA; STEROL;

ABSORPTION; CHOLESTEROL TRANSPORT; EXPLANT; HUMAN; HYPERCHOLESTEROLEMIA; INTESTINAL EXCRETION; INTESTINE CELL; LIVER; METABOLISM; NONHUMAN; NOTE; PLASMA; PRIORITY JOURNAL; REGULATORY MECHANISM; TRANSPORT AT THE CELLULAR LEVEL;

BIOLOGICAL TRANSPORT; CHOLESTEROL; HUMANS;

EID: 85029582256     PISSN: 02709139     EISSN: 15273350     Source Type: Journal    
DOI: 10.1002/hep.29341     Document Type: Note

References (8)

1. Stanley MM, Pineda EP, Cheng SH. Serum cholesterol esters and intestinal cholesterol secretion and absorption in obstructive jaundice due to cancer. N Engl J Med 1959;261:368-373.
2. Kruit JK, Plosch T, Havinga R, Boverhof R, Groot PH, Groen AK, et al. Increased fecal neutral sterol loss upon liver X receptor activation is independent of biliary sterol secretion in mice. Gastroenterology 2005;128:147-156.
3. Temel RE, Sawyer JK, Yu L, Lord C, Degirolamo C, McDaniel A, et al. Biliary sterol secretion is not required for macrophage reverse cholesterol transport. Cell Metab 2010;12:96-102.
4. de Boer JF, Schonewille M, Boesjes M, Wolters H, Bloks VW, Bos T, et al. Intestinal farnesoid X receptor controls transintestinal cholesterol excretion in mice. Gastroenterology 2017;152:1126-1138.
5. de Boer JF, Schonewille M, Dikkers A, Koehorst M, Havinga R, Kuipers F, et al. Transintestinal and biliary cholesterol secretion both contribute to macrophage reverse cholesterol transport in rats—brief report. Arterioscler Thromb Vasc Biol 2017;37:643-646.
6. Le May C, Berger JM, Lespine A, Pillot B, Prieur X, Letessier E, et al. Transintestinal cholesterol excretion is an active metabolic process modulated by PCSK9 and statin involving ABCB1. Arterioscler Thromb Vasc Biol 2013;33:1484-1493.
7. Jakulj L, van Dijk TH, de Boer JF, Kootte RS, Schonewille M, Paalvast Y, et al. Transintestinal cholesterol transport is active in mice and humans and controls ezetimibe-induced fecal neutral sterol excretion. Cell Metab 2016;24:783-794.
8. Wang DQ. Regulation of intestinal cholesterol absorption. Annu Rev Physiol 2007;69:221-248.